Evidence map›Paper›PMID 31562145›Full record

ArticleBMJ open2019

Current status and progression of lower urinary tract symptoms in Chinese male patients: the protocol and rationale for a nationwide, hospital-based, prospective, multicentre study.

Qi-Xiang Song, Yi Zhang, Xiaofei Ye, Wei Xue, Chuanliang Xu, Jing Xu, Paul Abrams, Yinghao Sun, Prostatic Obstruction Investigation Team (POInT)

Registry-linked trialAbstract read
In one paragraph

Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03394651 (The Current Status and Progression of Symptoms and Comorbidities Among Male Lower Urinary Tract Symptoms Patients in China), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03394651 unknown statusnot on this map

The Current Status and Progression of Symptoms and Comorbidities Among Male Lower Urinary Tract Symptoms Patients in China: a Multicenter Study From Prostatic Obstruction Investigation Team (POInT)

TypeobservationalSponsorChanghai HospitalRan2018 to 2022Enrolled11,500ConditionsLower Urinary Tract SymptomsArmsOral medications to treat lower urinary tract symptoms, Minimal invasive transurethral prostate procedures
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Qi-Xiang Song *Department of Urology, Changhai Hospital, Shanghai, China.ORCID 0000-0001-6393-9275
Yi Zhang *Department of Military Health Service, Naval Medical University, Shanghai, China.
Xiaofei YeDepartment of Health Statistics, Naval Medical University, Shanghai, China.
Wei XueDepartment of Urology, Renji Hospital, Shanghai Jiao Tong University, Shanghai, China.
Chuanliang XuDepartment of Urology, Changhai Hospital, Shanghai, China.
Jing XuDepartment of Nephrology, Changhai Hospital, Shanghai, China.
Paul AbramsBristol Urological Institute, Southmead Hospital, Bristol, UK.
Yinghao SunDepartment of Urology, Changhai Hospital, Shanghai, China sunyhsmmu@126.com.
Prostatic Obstruction Investigation Team (POInT)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIt has become increasingly evident that the male lower urinary tract symptoms (LUTS) may not only be caused by abnormalities in one or more components of the lower urinary tract, but also be secondary to a range of systemic disorders. The primary aim of this study is to evaluate the features of urological and systemic disorders among middle-aged and elderly male LUTS patients in China. The second aim is to investigate the changes of both conditions after interventions through a 2-year prospective follow-up. METHODS AND ANALYSIS: This nationwide, hospital-based, multicentre cohort study was designed and initiated by the Prostatic Obstruction Investigation Team which is an international multidisciplinary academic group focusing on the management of male LUTS. An expectation of 11 500 eligible subjects from 23 authorised urological centres across the mainland of China will be recruited with a baseline assessment and data collection. Subsequently, subjects will undergo a follow-up for 24 months having been prescribed with oral medications or after being selected for prostate surgery based on the standard practice of each institution as well as the clinician's own experience. All statistical analysis will be performed using SAS V.9.4 and R package. ETHICS AND DISSEMINATION: This study has received ethical approval from the Ethics Committee Boards of Shanghai Changhai Hospital (CHEC2017-244). The results will be reported at scientific conferences and be published on peer-reviewed journals.

trial registrationNCT03394651.

Indexed as

AgedChinaDisease ProgressionHumansLower Urinary Tract SymptomsMaleMiddle AgedMulticenter Studies as TopicObservational Studies as TopicProspective StudiesProstatic HyperplasiaResearch Designbenign prostatic hyperplasiabenign prostatic obstructioncomorbiditiesdetrusor overactivitydetrusor underactivitylower urinary tract symptoms

Identifiers

PMID31562145
PMCPMC6773293

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.